A woman in Nambour, Australia, is the first patient to receive a minimally invasive implantable neuromodulation device for severe migraine and cluster headache in a first-in-human study conducted by Salvia Bioelectronics BV.
/PRNewswire/ The "Neuromodulation Devices Global Market- Forecast To 2029" report has been added to ResearchAndMarkets.com s offering. The neuromodulation.
/PRNewswire/ Neurolief, a medical neurotechnology innovator, announces the appointment of Anthony Borowicz as Chief Financial Officer. "I m very pleased to.
/PRNewswire/ Neurolief, a medical neurotechnology company, announces the launch of a new Telehealth Channel to enhance patient access to the Relivion MG.